Here are four additional notes on Aurora Spine’s second-quarter financial results, according to an Aug. 21 news release from the company:
1. The company’s second quarter benefitted from a high demand in the pain management sector, specifically for the SiLO TFX and ZIP 51 implants.
2. The company’s gross margins improved to 62.4% in the second quarter of 2024, up from 56.9% in the same period last year.
3. Operating expenses for the second quarter were $2.74 million, up from $2.51 million in 2023.
4. The Company reported a net loss of $(0.154) million for the quarter, narrowing from a net loss of $(0.482) million in 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
